Table 1.
Correlation between clinicopathological parameters and the level of IDO1 in ovarian cancerous tissues.
| Clinicopathological Features | Case No. | IDO1 Expression Level | p Value | |
|---|---|---|---|---|
| Low (n = 33) | High (n = 35) | |||
| Age (year) | 0.492 | |||
| <50 | 24 | 13 (54.2%) | 11 (45.8%) | |
| ≥50 | 44 | 20 (45.5%) | 24 (54.5%) | |
| Histological type | 0.012 * | |||
| Serous | 54 | 22 (40.7%) | 32 (59.3%) | |
| Others | 14 | 11 (78.6%) | 3 (21.4%) | |
| Pathological grade | 0.447 | |||
| G1 | 2 | 2 (100.0%) | 0 (0.0%) | |
| G2 + G3 | 66 | 31 (47.0%) | 35 (53.0%) | |
| Classification | 0.201 | |||
| Type I | 16 | 10 (62.5%) | 6 (37.5%) | |
| Type II | 52 | 23 (44.2%) | 29 (55.8%) | |
| FIGO stage | 0.140 | |||
| I/II | 21 | 13 (61.9%) | 8 (38.1%) | |
| III/IV | 47 | 20 (42.6%) | 27 (57.4%) | |
| Platinum response | 0.015 * | |||
| Resistant | 22 | 6 (27.3%) | 16 (72.7%) | |
| Sensitive | 46 | 27 (58.7%) | 19 (41.3%) | |
FIGO: International Federation of Gynecology and Obstetrics; *: p < 0.05.